Differential Involvement of the Core and Shell Subregions of the Nucleus Accumbens in Conditioned Cue-induced Reinstatement of Cocaine Seeking in Rats
Overview
Affiliations
Rationale: The nucleus accumbens (NAC) is theorized to be a critical element of the neural circuitry that mediates relapse to cocaine seeking. Evidence suggests that the NAC is a functionally heterogeneous structure, and the core (NACc) and shell (NACs) regions of the NAC may play a differential role in stimulus-induced motivated behavior. Thus, determination of the involvement of NAC subregions in conditioned cue-induced reinstatement of cocaine seeking is warranted.
Objectives: The present study compared the effects of GABA agonist-induced inactivation of the NACc versus NACs on conditioned cue-induced reinstatement of cocaine seeking behavior.
Methods: Rats were trained to lever press for cocaine infusions (0.20 mg/infusion, IV) paired with presentations of a light-tone stimulus complex. Responding was then allowed to extinguish prior to reinstatement testing. Reinstatement of cocaine seeking (i.e. responses on the previously cocaine-paired lever) was measured in the presence of response-contingent presentation of the light-tone stimulus complex following microinfusion of muscimol+baclofen (Mus+Bac, 0.1/1.0 mM, respectively, 0.3 microl/side) or vehicle into the NACc or NACs. The effects of these manipulations on locomotor activity were also examined.
Results: Mus+Bac-induced inactivation of the NACc abolished, whereas inactivation of the NACs failed to alter, conditioned cue-induced reinstatement of operant responding relative to vehicle pretreatment. Time course analyses of the effects of these manipulations on locomotion versus operant responding confirmed that the effects of Mus+Bac on reinstatement were not due to suppression of general activity.
Conclusions: The functional integrity of the NACc, but not the NACs, is necessary for conditioned cue-induced reinstatement of cocaine seeking behavior.
Zhao H, Li H, Meng L, Du P, Mo X, Gong M Int J Neuropsychopharmacol. 2024; 28(1).
PMID: 39716383 PMC: 11700590. DOI: 10.1093/ijnp/pyae065.
Lai C, Chang C Front Behav Neurosci. 2023; 17:1252868.
PMID: 37781505 PMC: 10538645. DOI: 10.3389/fnbeh.2023.1252868.
Jenni N, Symonds N, Floresco S Psychopharmacology (Berl). 2022; 240(3):441-459.
PMID: 36322185 DOI: 10.1007/s00213-022-06265-8.
Sortman B, Gobin C, Rakela S, Cerci B, Warren B Front Behav Neurosci. 2022; 16:920667.
PMID: 36225390 PMC: 9549214. DOI: 10.3389/fnbeh.2022.920667.
Daiwile A, Sullivan P, Jayanthi S, Goldstein D, Cadet J Int J Mol Sci. 2022; 23(8).
PMID: 35457170 PMC: 9027322. DOI: 10.3390/ijms23084353.